ArticleACS medicinal chemistry letters2023

Discovery of Novel, Selective Prostaglandin EP4 Receptor Antagonists with Efficacy in Cancer Models.

Debasis Das et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.